Risk factor
Significant default risk
Profitability factor
Favourable analyst view
About
Samil Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company founded in 1947 that develops, manufactures, and sells a range of healthcare products. While its portfolio includes various medicines and medical devices, it has a particular specialization in ophthalmology (eye care). The company engages in the development of new drugs and also provides Contract Development and Manufacturing Organisation (CDMO) services.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is overvalued on EV/EBITDA.
Target Price
The average target price of 000520.KS is 10000 and suggests 42.9% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t